Literature DB >> 21430234

Cytochrome P450 2S1 is reduced by NADPH-cytochrome P450 reductase.

Yi Xiao1, Raku Shinkyo, F Peter Guengerich.   

Abstract

Cytochrome P450 (P450) 2S1 is one of the orphan P450s without a clear physiological function. Controversy has arisen as to whether it can interact with NADPH-P450 reductase and accept electrons. The reduction of 1,4-bis{[2-(dimethylamino-N-oxide)ethyl]amino}-5,8-dihydroxyanthracene-9,10-dione (AQ4N) by P450 2S1 was confirmed, and the NADPH consumption rates were measured aerobically and anaerobically in the absence and presence of the drug. The reduction kinetics of P450 2S1 were rapid, as measured by stopped-flow kinetics. These results confirm that P450 2S1 can be reduced by NADPH-P450 reductase and suggest normal mixed-function oxidase roles of P450 2S1 to be revealed.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21430234      PMCID: PMC3100906          DOI: 10.1124/dmd.111.039321

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  18 in total

1.  Identification of a novel dioxin-inducible cytochrome P450.

Authors:  Steven P Rivera; Sirkku T Saarikoski; Oliver Hankinson
Journal:  Mol Pharmacol       Date:  2002-02       Impact factor: 4.436

2.  Kinetics of ferric cytochrome P450 reduction by NADPH-cytochrome P450 reductase: rapid reduction in the absence of substrate and variations among cytochrome P450 systems.

Authors:  F P Guengerich; W W Johnson
Journal:  Biochemistry       Date:  1997-12-02       Impact factor: 3.162

3.  Spectral intermediates in the reaction of oxygen with purified liver microsomal cytochrome P-450.

Authors:  F P Guengerich; D P Ballou; M J Coon
Journal:  Biochem Biophys Res Commun       Date:  1976-06-07       Impact factor: 3.575

4.  Studies on the rate of reduction of hepatic microsomal cytochrome P-450 by reduced nicotinamide adenine dinucleotide phosphate: effect of drug substrates.

Authors:  P L Gigon; T E Gram; J R Gillette
Journal:  Mol Pharmacol       Date:  1969-03       Impact factor: 4.436

5.  High-performance liquid chromatographic analysis of AQ4N, an alkylaminoanthraquinone N-oxide.

Authors:  D J Swaine; P M Loadman; M C Bibby; M A Graham; L H Patterson
Journal:  J Chromatogr B Biomed Sci Appl       Date:  2000-06-09

6.  Role of the alanine at position 363 of cytochrome P450 2B2 in influencing the NADPH- and hydroperoxide-supported activities.

Authors:  I H Hanna; J F Teiber; K L Kokones; P F Hollenberg
Journal:  Arch Biochem Biophys       Date:  1998-02-15       Impact factor: 4.013

7.  Human CYP2S1 metabolizes cyclooxygenase- and lipoxygenase-derived eicosanoids.

Authors:  Peter Bui; Satoshi Imaizumi; Sudheer Reddy Beedanagari; Srinivasa T Reddy; Oliver Hankinson
Journal:  Drug Metab Dispos       Date:  2010-11-10       Impact factor: 3.922

8.  Rate-limiting steps in oxidations catalyzed by rabbit cytochrome P450 1A2.

Authors:  F Peter Guengerich; Joel A Krauser; William W Johnson
Journal:  Biochemistry       Date:  2004-08-24       Impact factor: 3.162

9.  Transformation of an arachidonic acid hydroperoxide into epoxyhydroxy and trihydroxy fatty acids by liver microsomal cytochrome P-450.

Authors:  R H Weiss; J L Arnold; R W Estabrook
Journal:  Arch Biochem Biophys       Date:  1987-01       Impact factor: 4.013

10.  Cytochrome P450-dependent transformations of 15R- and 15S-hydroperoxyeicosatetraenoic acids: stereoselective formation of epoxy alcohol products.

Authors:  M S Chang; W E Boeglin; F P Guengerich; A R Brash
Journal:  Biochemistry       Date:  1996-01-16       Impact factor: 3.162

View more
  16 in total

Review 1.  Contributions of human enzymes in carcinogen metabolism.

Authors:  Slobodan Rendic; F Peter Guengerich
Journal:  Chem Res Toxicol       Date:  2012-05-10       Impact factor: 3.739

Review 2.  Human Family 1-4 cytochrome P450 enzymes involved in the metabolic activation of xenobiotic and physiological chemicals: an update.

Authors:  Slobodan P Rendic; F Peter Guengerich
Journal:  Arch Toxicol       Date:  2021-01-18       Impact factor: 5.153

Review 3.  Orphans in the human cytochrome P450 superfamily: approaches to discovering functions and relevance in pharmacology.

Authors:  F Peter Guengerich; Qian Cheng
Journal:  Pharmacol Rev       Date:  2011-07-07       Impact factor: 25.468

4.  Bioactivation of fluorinated 2-aryl-benzothiazole antitumor molecules by human cytochrome P450s 1A1 and 2W1 and deactivation by cytochrome P450 2S1.

Authors:  Kai Wang; F Peter Guengerich
Journal:  Chem Res Toxicol       Date:  2012-07-10       Impact factor: 3.739

5.  A Role for the Orphan Human Cytochrome P450 2S1 in Polyunsaturated Fatty Acid ω-1 Hydroxylation Using an Untargeted Metabolomic Approach.

Authors:  Mostafa I Fekry; Yi Xiao; Jeannette Zinggeler Berg; F Peter Guengerich
Journal:  Drug Metab Dispos       Date:  2019-09-11       Impact factor: 3.922

6.  Generation and characterization of a novel Cyp2a(4/5)bgs-null mouse model.

Authors:  Yuan Wei; Lei Li; Xin Zhou; Qing-Yu Zhang; Anwar Dunbar; Fang Liu; Kerri Kluetzman; Weizhu Yang; Xinxin Ding
Journal:  Drug Metab Dispos       Date:  2012-10-16       Impact factor: 3.922

7.  Reduction of aromatic and heterocyclic aromatic N-hydroxylamines by human cytochrome P450 2S1.

Authors:  Kai Wang; F Peter Guengerich
Journal:  Chem Res Toxicol       Date:  2013-05-29       Impact factor: 3.739

8.  Cytochrome P450 2S1 depletion enhances cell proliferation and migration in bronchial epithelial cells, in part, through modulation of prostaglandin E(2) synthesis.

Authors:  T W Madanayake; T P Fidler; T M Fresquez; N Bajaj; A M Rowland
Journal:  Drug Metab Dispos       Date:  2012-08-03       Impact factor: 3.922

9.  Impact of tumor blood flow modulation on tumor sensitivity to the bioreductive drug banoxantrone.

Authors:  Eugene Manley; David J Waxman
Journal:  J Pharmacol Exp Ther       Date:  2012-11-28       Impact factor: 4.030

Review 10.  Unusual cytochrome p450 enzymes and reactions.

Authors:  F Peter Guengerich; Andrew W Munro
Journal:  J Biol Chem       Date:  2013-04-30       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.